Cargando…
Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development
The recent outbreak of the betacoronavirus SARS-CoV-2 has become a significant concern to public health care worldwide. As of August 19, 2020, more than 22,140,472 people are infected, and over 781,135 people have died due to this deadly virus. In the USA alone, over 5,482,602 people are currently i...
Autores principales: | Samrat, Subodh Kumar, Tharappel, Anil M., Li, Zhong, Li, Hongmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443330/ https://www.ncbi.nlm.nih.gov/pubmed/32846196 http://dx.doi.org/10.1016/j.virusres.2020.198141 |
Ejemplares similares
-
Inteins as Drug Targets and Therapeutic Tools
por: Tharappel, Anil Mathew, et al.
Publicado: (2022) -
Allosteric inhibitors of the main protease of SARS-CoV-2
por: Samrat, Subodh Kumar, et al.
Publicado: (2022) -
The main protease of SARS-CoV-2 downregulates innate immunity via a translational repression
por: Liang, Weifeng, et al.
Publicado: (2023) -
The spike protein of SARS-CoV — a target for vaccine and therapeutic development
por: Du, Lanying, et al.
Publicado: (2009) -
MERS-CoV spike protein: Targets for vaccines and therapeutics
por: Wang, Qihui, et al.
Publicado: (2016)